Attached files
| file | filename |
|---|---|
| EX-99.2 - UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - HEAT BIOLOGICS, INC. | htbx_ex99z2.htm |
| EX-99.1 - AUDITED FINANCIAL STATEMENTS - HEAT BIOLOGICS, INC. | htbx_ex99z1.htm |
| 8-K/A - CURRENT REPORT - AMENDMENT NO. 1 - HEAT BIOLOGICS, INC. | htbx_8k.htm |
EXHIBIT 23.1
Consent of Independent Auditor
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-199274 and No. 333-214868) and Form S-8 (No. 333-193453, No. 333-196763, No. 333-207108 and No. 333-213133) of Heat Biologics, Inc. of our report dated July 10, 2017, relating to the financial statements of Pelican Therapeutics, Inc. which appears in this Form 8-K/A. Our report contains an explanatory paragraph regarding Pelican Therapeutics, Inc.’s ability to continue as a going concern.
/s/ BDO USA, LLP
Raleigh, North Carolina
July 10, 2017